MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
MPM Capital - TEDCO
Finance & Acquisitions: MPM
Parents
MPM Capital - TEDCO
Children
*Portfolio Companies: MPM Capital
2008: With Backing From MPM and Kleiner Perkins, EpiZyme Aims to Turn Genes On and Off
2011: $7.5 million investment by MPM Capital (2011)
2011: $91 million 4th round includes GE Capital, Healthcare Financial Services, Oxford Finance LLC, BB Biotech AG, Brookside Capital, Saints Capital, Nordic Bioscience Ipsen Pharma SAS, MPM Capital, BB Biotech Ventures, MPM Bio IV NVS Strategic Fund, The
2020: MPM Capital, Dana-Farber Announce Venture Philanthropy Collaboration
Amount: $1M Round: Venture Capital Past Investor(s) Biomedical Advanced Research and Development Authority, MPM Capital, BD Ventures, Allen & Company, Sagamore BioVentures, Eminent Venture Capital, Camelot Ventures, Cheng Xin Technology Development
Cerimon raised $70 million from MPM Capital, OrbiMed Advisors and Phase4 Ventures
Existing investors participating in this financing round included Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic, MPM Capital, and Three Arch Partners.
Frazier Healthcare Ventures led the round. Existing investors MPM Capital, Interwest Partners and Polaris Venture Partners all participated in the financing.
Hamilton BioVentures and Alta Partners led the deal, which included MPM Capital and Investor Growth Capital
Iinvestors include Celgene, Advanced Technology Ventures, Avalon Ventures, Bessemer Venture Partners, Flagship Ventures, Polaris Venture Partners, MPM BioEquities, OrbiMed Advisors, QVT Financial, Sutter Hill Ventures and Venrock.
Investors: InterSouth Partners, MPM Capital
Kleiner Perkins Caufield & Byers, MPM Capital, SR One, Biogen Idec New Ventures and Baxter Ventures participated in the Series A round, which includes proceeds from True North's spin-off from iPerian Inc. in 2013.
Other investors include MPM Capital, Pitango Venture Capital, Abingworth, Advanced Technology Ventures, ONSET Ventures, HLM Venture Partners, Agate Medical Investments, CHL Medical Partners and Kaiser Permanente Ventures.
Other participants are Advanced Technology Ventures, MPM Capital, Foundation Medical Partners, Chicago Growth Partners, and De N
Participants include Longwood Founders Fund, Bessemer Venture Partners, Cardinal Partners and MPM Capital.
Participants include MPM Capital and ProQuest Investments.
Participants include MPM Capital, Cultivian Ventures and Avalon Ventures.
The round was led by MPM Capital and New Enterprise Associates.
The Series B financing includes new investor MPM Capital and the existing investor, ProQuest Investments
Venture backers include Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital, Google Ventures, GlaxoSmithKline’s SR One, FinTech Global Capital, Mitsubishi UFJ Capital, Mission Bay Capital, Atel Ventures, and Biogen Idec New Ventures
VENTURE FUNDING TOTAL $55M - Texas Pacific Group, MPM Capital, ARCH Venture Partners, OVP Venture Partners, Amgen Ventures, MedImmune Ventures, WRF Capital (2006)
Venture investors include ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.
Venturi Group, LLC
Jumps
*Key People: MPM
Organization & Developments: MPM